This is a profile image of Mohammad Behnam

Mohammad Behnam


Leverages extensive education and work experience in the medical-device and life-science sectors to help global medical device and digital healthcare clients transform operations and drive sustainable growth

Moh coleads McKinsey’s medical products operations work globally. He brings more than 15 years of experience to his work with clients in the medical-device, pharmaceutical, and life-science industries on operations issues including product development, supply chain, procurement, manufacturing, and quality and compliance.

Moh helps medical-device and technology clients to develop strategies and pursue operational transformations that spur innovation and unlock sustainable growth.

Examples of his recent engagement experience include the following:

  • leading multiple end-to-end operations diagnostics and transformations for leading medical-device companies, including manufacturing and distribution-network optimization and manufacturing, quality, and SKU rationalization
  • performing multiple preacquisition due diligences on products, manufacturing, supply chain, and quality for various private-equity and medical-device clients, and developing tactical integration plans to mitigate risks after acquisitions
  • leading multiple product-development and design projects focused on emerging technologies and applications
  • developing a medical-device launch and integration strategy within the healthcare ecosystem
  • developing an infectious disease diagnostic and management network strategy in a highly complex environment

Before joining McKinsey, Moh founded a medical device company that integrated cutting-edge micro and nano technologies to introduce point-of-care molecular diagnostic devices. The company was recognized as one of Canada's top ten life-science companies. He also held a strategic marketing role with a medical-technology company in Singapore. Earlier in his career. Moh was an assembly and maintenance technician for medical-imaging devices.

Published work

COVID-19 and in vitro diagnostics: New market forces at play,” McKinsey & Company, December 2020

Medtech’s call to action: Meeting the demand surge caused by COVID-19,” McKinsey & Company, September 2020

COVID-19 exposes a critical shortage of oxygen in developing countries,” McKinsey & Company, August 2020

COVID-19: Overcoming supply shortages for diagnostic testing,” McKinsey & Company, July 2020

Rethinking manufacturing and distribution networks in medtech,” McKinsey & Company, December 2019

Past Experience

Biolithic Corporation
Cofounder, chief technology officer

Becton Dickinson and Company
Strategic marketing

University of Alberta Nanofabrication, Alberta Cross Cancer Institute, and DALSA Semiconductor
Research associate


University of Alberta
PhD, nano/micro technologies, molecular diagnostics
MSc, electrical engineering, microelectronics